certify

Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.

March 26, 2023 456 Views
Although Ipsen’s Palovarotene was rejected by the FDA just three months ago, the rare disease candidate’s story is ...
December 5, 2018 3265 Views
French pharmaceutical company, Ipsen, seeks to grow its operations in North America, following its decision earlier this year ...
banner
Adsense